The parathyroid gland is significantly involved in the pathogenesis of CKD and SHPT, as well as a target of vitamin D receptor agonist (VDRA) therapy; thus, it is important that further studies focused on parathyroid megalin be undertaken. This evidence concerns the gene VDR and chronic kidney disease.